Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET-PA) Receivables (2016 - 2025)

Historic Receivables for Metlife (MET-PA) over the last 17 years, with Q3 2025 value amounting to $3.3 billion.

  • Metlife's Receivables rose 839.44% to $3.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 billion, marking a year-over-year increase of 839.44%. This contributed to the annual value of $32.6 billion for FY2024, which is 313.02% up from last year.
  • Per Metlife's latest filing, its Receivables stood at $3.3 billion for Q3 2025, which was up 839.44% from $3.3 billion recorded in Q2 2025.
  • Over the past 5 years, Metlife's Receivables peaked at $34.2 billion during Q1 2025, and registered a low of $2.8 billion during Q2 2022.
  • Over the past 5 years, Metlife's median Receivables value was $19.8 billion (recorded in 2022), while the average stood at $18.2 billion.
  • Its Receivables has fluctuated over the past 5 years, first tumbled by 8686.96% in 2022, then skyrocketed by 66163.0% in 2023.
  • Quarter analysis of 5 years shows Metlife's Receivables stood at $19.8 billion in 2021, then increased by 0.19% to $19.8 billion in 2022, then skyrocketed by 59.28% to $31.6 billion in 2023, then rose by 3.13% to $32.6 billion in 2024, then tumbled by 90.0% to $3.3 billion in 2025.
  • Its Receivables stands at $3.3 billion for Q3 2025, versus $3.3 billion for Q2 2025 and $34.2 billion for Q1 2025.